Matinas BioPharma Holdings, Inc. (MTNB)
1.701
-0.01
(-0.55%)
USD |
NYAM |
Oct 23, 16:00
1.71
+0.01
(+0.55%)
After-Hours: 20:00
Matinas BioPharma Holdings Price to Book Value : 0.4035 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 0.4035 |
| October 22, 2026 | 0.4057 |
| October 21, 2026 | 0.3607 |
| October 20, 2026 | 0.4034 |
| October 19, 2026 | 0.3939 |
| October 16, 2026 | 0.5623 |
| October 15, 2026 | 0.5742 |
| October 14, 2026 | 0.5884 |
| October 13, 2026 | 0.5932 |
| October 12, 2026 | 0.6501 |
| October 09, 2026 | 0.681 |
| October 08, 2026 | 0.6715 |
| October 07, 2026 | 0.6573 |
| October 06, 2026 | 0.7142 |
| October 05, 2026 | 0.6691 |
| October 02, 2026 | 0.6264 |
| October 01, 2026 | 0.5742 |
| September 30, 2026 | 0.6051 |
| September 29, 2026 | 0.6834 |
| September 28, 2026 | 0.6003 |
| September 25, 2026 | 0.5695 |
| September 24, 2026 | 0.6335 |
| September 23, 2026 | 0.6229 |
| September 22, 2026 | 0.63 |
| September 21, 2026 | 0.6189 |
| Date | Value |
|---|---|
| September 18, 2026 | 0.5709 |
| September 17, 2026 | 0.5801 |
| September 16, 2026 | 0.5876 |
| September 15, 2026 | 0.5695 |
| September 14, 2026 | 0.6834 |
| September 11, 2026 | 0.6584 |
| September 10, 2026 | 0.7296 |
| September 09, 2026 | 0.6538 |
| September 08, 2026 | 0.6478 |
| September 04, 2026 | 0.6478 |
| September 03, 2026 | 0.6442 |
| September 02, 2026 | 0.662 |
| September 01, 2026 | 0.7036 |
| August 31, 2026 | 0.7036 |
| August 28, 2026 | 0.7118 |
| August 27, 2026 | 0.7118 |
| August 26, 2026 | 0.699 |
| August 25, 2026 | 0.7022 |
| August 24, 2026 | 0.6994 |
| August 21, 2026 | 0.7076 |
| August 20, 2026 | 0.6495 |
| August 19, 2026 | 0.8578 |
| August 18, 2026 | 0.725 |
| August 17, 2026 | 0.7908 |
| August 14, 2026 | 0.8328 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Anika Therapeutics, Inc. | 2.088 |
| Savara, Inc. | 6.034 |
| Vericel Corp. | 5.881 |
Price to Book Value Related Metrics
| Price | 1.701 |
| Earnings Yield | -1.06K% |
| Market Cap | 0.7263M |